Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes

Author(s):
Genovese, M.C.; Adelsberg, J. van; Fan, C.P.; Graham, N.M.H.; Hoogstraten, H. van; Parrino, J.; Mangan, E.K.; Spindler, A.; Huizinga, T.W.J.; Heijde, D. van der; EXTEND Study Investigators
Published
2018
Publication type
Article / Letter to editor
sarilumabrheumatoid arthritisIL-6radiographic outcomesdisease activityphysical function
Date issued
2018-08-31
Language
English
Is part of
Rheumatology (2018), Vol. 57, no. 8, p. 1423-1431
hdl
1887/76242
doi
10.1093/rheumatology/key121
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055572/pdf/key121.pdf